ESROLAS Trademark

Trademark Overview

On Tuesday, March 16, 2021, a trademark application was filed for ESROLAS with the United States Patent and Trademark Office. The USPTO has given the ESROLAS trademark a serial number of 90583044. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, June 20, 2024. This trademark is owned by Sermonix Pharmaceuticals, Inc.. The ESROLAS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of breast cancer

General Information

Serial Number90583044
Word MarkESROLAS
Filing DateTuesday, March 16, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, June 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 23, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of breast cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSermonix Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressColumbus, OH 43215
Party NameSermonix Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressColumbus, OH 43209

Trademark Events

Event DateEvent Description
Friday, March 19, 2021NEW APPLICATION ENTERED
Tuesday, June 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 14, 2021ASSIGNED TO EXAMINER
Sunday, October 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 23, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 8, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 8, 2022SOU EXTENSION 1 FILED
Friday, July 8, 2022SOU EXTENSION 1 GRANTED
Tuesday, July 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 11, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 11, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 10, 2023SOU EXTENSION 2 FILED
Tuesday, January 10, 2023SOU EXTENSION 2 GRANTED
Thursday, January 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 6, 2023SOU EXTENSION 3 FILED
Thursday, July 6, 2023SOU EXTENSION 3 GRANTED
Saturday, July 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 5, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 5, 2024SOU EXTENSION 4 FILED
Friday, January 5, 2024SOU EXTENSION 4 GRANTED
Tuesday, January 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 20, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 20, 2024SOU EXTENSION 5 GRANTED
Thursday, June 20, 2024SOU EXTENSION 5 FILED
Friday, November 15, 2024TEAS STATEMENT OF USE RECEIVED

Related Keywords

esrolas cancer breast treatment preparations pharmaceutical